Corporate ActionOct 23, 2026, 04:11 PM
Aptevo Therapeutics Extends Rights Agreement Expiration to Oct 2027, Adjusts Purchase Price
AI Summary
Aptevo Therapeutics Inc. has entered into Amendment No. 6 to its Rights Agreement, originally dated November 8, 2020. This amendment extends the Final Expiration Date of the agreement to October 23, 2027. Additionally, the Purchase Price for the contingent rights to purchase preferred stock has been adjusted to $14.56 per one one-thousandth of a share.
Key Highlights
- Aptevo Therapeutics amended its Rights Agreement dated November 8, 2020.
- The amendment extends the Final Expiration Date of the Rights Agreement to October 23, 2027.
- The Purchase Price per one one-thousandth of a Preferred Share was changed to $14.56.
Price Impact
More from APVO